Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 13Genitourinary 9Head & Neck 8Gastrointestinal 7Gynecologic 6Other hematologic neoplasm 5Breast 3Other neoplasm 2

Conditions

Precancerous Conditions 54Multiple Myeloma 10Lymphoma 10Neoplasms, Plasma Cell 9Leukemia 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, T-Cell, Cutaneous 8Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Burkitt Lymphoma 8Myeloproliferative Disorders 7Myelodysplastic Syndromes 7Lymphoma, Large-Cell, Anaplastic 7Keratosis, Actinic 7Immunoblastic Lymphadenopathy 7Waldenstrom Macroglobulinemia 6Sezary Syndrome 6Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Mycosis Fungoides 6Lymphoma, Extranodal NK-T-Cell 6Leukemia, Myelomonocytic, Chronic 6

Interventions

Sulindac 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Tobacco Use Disorder × Other neoplasm × Clear all
NCT00690924 2018-06-04

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer

Roswell Park Cancer Institute

Phase NA Completed
16 enrolled 6 charts
Other neoplasmThoracic

Lung Neoplasms, Precancerous Conditions, Tobacco Use Disorder

NCT00368927 2014-05-23

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed
61 enrolled 11 charts
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Precancerous Conditions, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡